Chinese Mine Shutdown: Is This the Perfect Time to Invest in ASX Lithium Stocks?
The closure of a significant lithium mine run by CATL in China has sent shockwaves through the global lithium market.…
The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!
The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and…
Gearing: What is it and how can companies exploit it to their advantage?
You may hear a company talk about its gearing. Generally only when it has a low level of gearing, of…
After Nvidia’s Rally: Is It Time to Invest in Asian Chip Stocks?
Nvidia, a top-tier company in the world of graphics processing units (GPUs), has recently enjoyed a meteoric rise in its…
Blackstone Minerals (ASX:BSX): Straw hats in winter
Blackstone Minerals (ASX:BSX): Summer is coming Back in early 2022, Blackstone Minerals was riding high. The Perth-based resource junior, at…
Private Credit: What is it and why has this US$1tn market become such a popular investment option?
Private credit is a US$1 trillion (A$1.49tn) market and $200bn in Australia alone. It is clearly worth knowing about and…
How Many Stocks Should You Have in a Portfolio?
The amount of shares to buy can be an instrumental choice that might define your investment strategy and serve as…
Is the September Effect Real? Here’s What the Historical Data says and The Challenge Facing Investors
One of the perceived market phenomena is the “September Effect,” observed when the monthly returns during the month of September…
IPhone 16 Launch Event: Should You Buy Apple Stock Now
The highly awaited event of Apple witnessed the launch of the iPhone 16 series on September 9, 2024. It launches…
Invion (ASX:IVX): Using Photodynamic Therapy to fight cancer
Unless you’re a professional dermatologist, you may not have ever heard of Photodynamic Therapy, let alone thought of it as…
Bio Gene Technology (ASX:BGT): Commercialising a new class of insecticides
Bio Gene Technology (ASX:BGT) ASX-listed AgTech company developing two compounds – Flavocide™ and Qcide™ – as insecticides. Investors may hear…
Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years
If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…
Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017
Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…
Humm Group (ASX:HUM): Its no Big 4 Bank, but has defied the market in 2024
Humm Group (ASX:HUM) has not had the year you might expect to a financier that is not either a Big…
Percheron Therapeutics (ASX:PER): Releasing Phase II data by the end of CY24, and successful data could lead to a major re-rate
It has been less then a year since Antisense Therapeutics changed its name to Percheron Therapeutics (ASX:PER). It is common…